Cargando…

Relationship between ovarian cancer stem cells, epithelial mesenchymal transition and tumour recurrence

Investigating the biological processes that occur to enable recurrence and the development of chemoresistance in ovarian cancer is critical to the research and development of improved treatment options for patients. The lethality of ovarian cancer is largely attributed to the recurrence of disease w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Padilla, Monica Angelica Amaya, Binju, Mudra, Wan, Graeme, Rahmanto, Yohan Suryo, Kaur, Pritinder, Yu, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019200/ https://www.ncbi.nlm.nih.gov/pubmed/35582283 http://dx.doi.org/10.20517/cdr.2019.76

Ejemplares similares

Therapeutic Inducers of Apoptosis in Ovarian Cancer
por: Binju, Mudra, et al.
Publicado: (2019)

Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?
por: Rendell, Aimee, et al.
Publicado: (2022)

Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer
por: Yu, Yu, et al.
Publicado: (2019)

Epithelial–Mesenchymal Transition in Ovarian Carcinoma
por: Davidson, Ben, et al.
Publicado: (2012)

Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors
por: Ayhan, Ayse, et al.
Publicado: (2015)

Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial–mesenchymal transition
por: Yang, Jiani, et al.
Publicado: (2021)

N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion
por: Lane, Darius J. R., et al.
Publicado: (2013)

Correction: N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion
por: Lane, Darius J. R., et al.
Publicado: (2016)

Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway
por: Yu, Yu, et al.
Publicado: (2018)

Pericytes, Mesenchymal Stem Cells and the Wound Healing Process
por: Mills, Stuart J., et al.
Publicado: (2013)

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
por: Chiu, Wen-Tai, et al.
Publicado: (2014)

Epithelial–Mesenchymal Transition (EMT)
por: Manfioletti, Guidalberto, et al.
Publicado: (2023)

Expression Profiles of Epithelial-Mesenchymal Transition-Associated Proteins in Epithelial Ovarian Carcinoma
por: Kim, Mi-Kyung, et al.
Publicado: (2014)

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
por: Kobayashi, Yusuke, et al.
Publicado: (2017)

NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
por: Qin, Shan, et al.
Publicado: (2017)

Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
por: Yang, Hui-Wen, et al.
Publicado: (2023)

Epithelial–Mesenchymal Transition (EMT) 2021
por: Manfioletti, Guidalberto, et al.
Publicado: (2022)

Thrombin promotes epithelial ovarian cancer cell invasion by inducing epithelial-mesenchymal transition
por: Zhong, Yi-Cun, et al.
Publicado: (2013)

The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells
por: Gou, Wen-feng, et al.
Publicado: (2014)

Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
por: Chen, Chen, et al.
Publicado: (2019)

SOX11 and Epithelial-Mesenchymal Transition in Metastatic Serous Ovarian Cancer
por: Psilopatis, Iason, et al.
Publicado: (2023)

Epithelial Mesenchymal Transition (EMT) and Associated Invasive Adhesions in Solid and Haematological Tumours
por: Greaves, David, et al.
Publicado: (2022)

Cyclin D1 affects epithelial–mesenchymal transition in epithelial ovarian cancer stem cell-like cells
por: Jiao, Jie, et al.
Publicado: (2013)

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism
por: Leung, Dilys, et al.
Publicado: (2022)

HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition
por: Xu, Long, et al.
Publicado: (2022)

Cytoplasmic SIRT1 inhibits cell migration and invasion by impeding epithelial–mesenchymal transition in ovarian carcinoma
por: Yang, Tong, et al.
Publicado: (2019)

Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer
por: Liu, Na, et al.
Publicado: (2017)

MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
por: Vos, Maria Caroline, et al.
Publicado: (2016)

Knockout of MTF1 Inhibits the Epithelial to Mesenchymal Transition in Ovarian Cancer Cells
por: Ji, Liang, et al.
Publicado: (2018)

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
por: Deng, Junli, et al.
Publicado: (2016)

EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells
por: Cardenas, Horacio, et al.
Publicado: (2016)

Exosome Secretion and Epithelial-Mesenchymal Transition in Ovarian Cancer Are Regulated by Phospholipase D
por: Onallah, Hadil, et al.
Publicado: (2022)

Ex vivo assessment of targeted therapies in a rare metastatic epithelial–myoepithelial carcinoma
por: Mäkelä, Rami, et al.
Publicado: (2020)

DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells
por: Zhang, Lili, et al.
Publicado: (2018)

HOXA‑AS3 induces tumor progression through the epithelial‑mesenchymal transition pathway in epithelial ovarian cancer
por: Eoh, Kyung Jin, et al.
Publicado: (2023)

PTIP promotes recurrence and metastasis of hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Leng, Shusheng, et al.
Publicado: (2017)

Involvement of epithelial–mesenchymal transition in liver fibrosis
por: Yu, Kangkang, et al.
Publicado: (2018)

Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition
por: Ranieri, Danilo, et al.
Publicado: (2015)

EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma
por: Fan, Chi-Chen, et al.
Publicado: (2017)

Dermal Contributions to Human Interfollicular Epidermal Architecture and Self-Renewal
por: Lawlor, Kynan T., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p9dp562pcocc5pbvd1fd2gbisu